GAMMA Investing’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97K Buy
943
+185
+24% +$12K ﹤0.01% 1834
2026
Q1
$36K Buy
758
+262
+53% +$11.7K ﹤0.01% 2400
2025
Q4
$15.7K Buy
496
+239
+93% +$7.46K ﹤0.01% 2741
2025
Q3
$7.23K Buy
257
+28
+12% +$848 ﹤0.01% 3034
2025
Q2
$8.43K Sell
229
-519
-69% -$17.9K ﹤0.01% 2898
2025
Q1
$29.4K Buy
748
+303
+68% +$13.6K ﹤0.01% 2173
2024
Q4
$20.7K Buy
445
+170
+62% +$7.68K ﹤0.01% 2249
2024
Q3
$12.4K Sell
275
-3,479
-93% -$166K ﹤0.01% 2362
2024
Q2
$185K Buy
3,754
+3,566
+1,897% +$145K 0.03% 523
2024
Q1
$6.45K Buy
188
+18
+11% +$650 ﹤0.01% 2292
2023
Q4
$5.51K Buy
+170
New +$3.93K ﹤0.01% 2195

Other funds holding TWST

GAMMA Investing's TWST Position: Q2 2026 in Review

GAMMA Investing increased its Twist Bioscience (TWST) stake by 24% in Q2 2026, buying an estimated $12K and bringing the position to 943 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

GAMMA Investing first reported a position in TWST in Q4 2023 and has held it in 11 quarters since. The position peaked at $185K in Q2 2024. 33 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • GAMMA Investing held 943 shares of Twist Bioscience worth $97K as of Q2 2026.
  • GAMMA Investing bought 185 Twist Bioscience shares in Q2 2026, an estimated $12K.
  • Twist Bioscience made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1834 holding.
  • GAMMA Investing first reported a position in Twist Bioscience in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Twist Bioscience position peaked at $185K in Q2 2024.
  • 33 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.